Cost effectiveness of omalizumab for severe asthma in Colombia

Jefferson Antonio Buendíaa Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK;b Research group in Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Antioquia, Medellín, ColombiaCorrespondence[email protected]

https://orcid.org/0000-0003-2404-6612 View further author information

, MD PhD

Diana Guerrero Patiñob Research group in Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Antioquia, Medellín, ColombiaView further author information

, RN, MSC &

Andrés Felipe Zuluaga Salazarb Research group in Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Antioquia, Medellín, Colombia;c Laboratorio Integrado de Medicina Especializada (LIME), Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Antioquia, ColombiaView further author information

, MD MSc

Cost effectiveness of omalizumab for severe asthma in Colombia

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cost effectiveness of omalizumab for severe asthma in Colombia

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date